LIM BRYANT DAVID (CLO, CFO, Corp Sec.) purchased 1041.7% of their position (25K shares) of PRELUDE THERAPEUTICS INC on the open market
Open‑market purchase worth $22.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/20/2024ACC: 0001562180-24-008532
Officer· CLO, CFO, Corp Sec.
Since Feb 2026
+25K
Net shares
Net buyer
$22.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$0.91
Trade value
$22.64K
% of position
1041.7%
12/19/2024
2.40K→27.40K
Total
Net shares
+25K
Net value
$22.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2024 | P · Purchase | +25K | $0.91 | $22.64K | 1041.7% | 2.40K | 27.40K |
| Total | +25K | $22.64K | ||||||
Derivative Transactions0
No derivative transactions reported